Creative Touch Permanent Makeup and Aesthetics

The stratum corneum is the skin’s definitive interface, functioning as a “bricks and mortar” system where anucleate corneocytes (the bricks) are embedded in a lamellar lipid matrix (the mortar). Clinical integrity depends on more than just lipid quantity; it requires a precise acidic pH (4.5–5.5) to activate the enzymes responsible for ceramide processing and controlled desquamation. Effective barrier restoration is a dual-track process: we must support the upstream keratinocyte differentiation programme while maintaining the acidic surface environment that allows the barrier to self-assemble and shed correctly.

The stratum corneum is the terminal product of keratinocyte differentiation – the layer at which the elaborate upward journey from basal cell to corneocyte concludes. It is thin (10–40 μm depending on body site), structurally dense, and functionally non-negotiable: without an intact stratum corneum, the epidermis cannot regulate water loss, exclude environmental threats, or maintain the acid pH environment on which its own lipid-processing enzymes depend. It is the layer that all the upstream biology of the Keratinocyte, Filaggrin, Ceramide, and Free Fatty Acid entities is ultimately building toward.

Two Components, Two Functions

The stratum corneum operates through two structurally distinct components whose functions are complementary but independent. ^[5]

Corneocytes are the anucleate, keratin-filled cells that provide mechanical reinforcement – the physical resistance to abrasion, UV damage, and pathogen penetration. Each corneocyte is surrounded by a cornified envelope, a highly cross-linked protein shell replacing the original plasma membrane during terminal differentiation. Inside, keratin filaments are compacted within a filaggrin protein matrix, giving the cell its characteristic flat, dense architecture. Corneocytes remain connected to adjacent cells by corneodesmosomes – modified desmosomes that are progressively degraded by serine proteases toward the surface, orchestrating the controlled shedding process of desquamation.

The extracellular lipid matrix fills the intercellular spaces between corneocytes in a highly organised lamellar arrangement – ceramides, cholesterol, and free fatty acids stacked in repeating bilayer phases that create the primary waterproof seal of the barrier. This is the component responsible for regulating transepidermal water loss (TEWL) and for controlling the selective permeability that determines what the barrier lets through and what it excludes. The lipid matrix is not simply a passive sealant. It is the source of the acidic pH environment – generated through free fatty acid release by secretory phospholipase A2 – that activates the ceramide-processing enzymes essential for its own maintenance. It also hosts antimicrobial peptides that contribute to surface-level pathogen defence.

These two components fail through different mechanisms and require different approaches to restoration, which is the primary reason that treating stratum corneum dysfunction as a single problem produces incomplete outcomes. Corneocyte quality depends on the completeness of the keratinocyte differentiation programme, the filaggrin content of the cell, and the integrity of the cornified envelope. Lipid matrix quality depends on the synthesis capacity of differentiating keratinocytes, the availability of ceramide, cholesterol, and free fatty acid precursors, and the acid pH environment in which lamellar body secretion and lipid processing occur. ^[5]

The “Bricks and Mortar” Anatomy

The Stratum Disjunctum: The Desquamation Zone

The stratum disjunctum is the upper portion of the stratum corneum – the zone in which corneocytes are progressively losing their intercellular adhesion and moving toward active shedding from the skin surface. It is not a structurally distinct layer visible in histology but a functional zone defined by the progressive degradation of the corneodesmosomes that, in the stratum compactum below, are still intact and load-bearing.

The transition from compactum to disjunctum is driven by a serine protease cascade centred on two kallikrein-related peptidases, KLK5 and KLK7, secreted as inactive precursors from lamellar granules in the upper stratum granulosum and activated in the intercellular space of the stratum corneum. KLK5 is the cascade initiator – it self-activates and then cleaves and activates KLK7 and KLK14; KLK14 feeds back positively to amplify KLK5 activity, creating a self-reinforcing proteolytic cascade. ^[6] Activated KLK5 and KLK7 then degrade the three structural proteins of the corneodesmosome – desmoglein-1 (DSG1), desmocollin-1 (DSC1), and corneodesmosin (CDSN) – progressively dissolving the intercellular adhesion that held those cells in place. Once corneodesmosomal integrity is lost, the corneocyte can no longer be retained, and desquamation follows.

The enzyme cascade is regulated at the stratum disjunctum level by the serine protease inhibitor LEKTI (lympho-epithelial Kazal-type-related inhibitor, encoded by SPINK5), which binds KLK5 to hold the cascade in check. LEKTI’s inhibitory grip on KLK5 is directly pH-dependent: as the epidermal pH gradient acidifies toward the surface, LEKTI dissociates from KLK5, releasing active protease and permitting corneodesmosomal cleavage to occur precisely in the most superficial stratum corneum layers. ^[2] Desquamation is therefore pH-gated: the acid mantle’s maintenance of the correct surface pH is not just an antimicrobial function but an active regulator of the timing and location of corneodesmosomal cleavage.

When this system is dysregulated – through SPINK5 mutation (Netherton syndrome), KLK5/7 upregulation ( atopic dermatitis and psoriasis), or alkaline pH disruption of the gradient that normally confines protease activity to the disjunctum – desquamation accelerates uncontrollably, barrier integrity collapses, and the inflammatory cascade that follows produces the clinical presentations of those conditions. ^[1] The same mechanism explains why sustained alkaline pH exposure – harsh surfactants, hard water, repeated alkaline cleanser use – produces clinical barrier dysfunction even in skin without underlying genetic risk: the acid gradient that confines KLK activity to the disjunctum is disrupted, and proteolytic activity spreads downward into the compactum.

Clinical significance for topical exfoliation: Glycolic acid’s exfoliating action is specifically targeted to the stratum disjunctum. Biopsy evidence confirms that enhanced corneodesmosomal breakdown under glycolic acid treatment is restricted to the disjunctum – accelerating the KLK-driven dissolution that is already occurring there – whilst desmosomes in the stratum compactum remain entirely unaffected. ^[3] This selectivity is why well-formulated chemical exfoliants do not strip the barrier: they amplify the disjunctum’s own controlled desquamation process without penetrating to the compactum’s intact adhesion structures.

The Stratum Compactum: The Barrier Zone

The stratum compactum is the lower portion of the stratum corneum – the mechanically robust, biochemically intact zone that performs the primary barrier functions of TEWL regulation, selective permeability, and physical resistance. Where the disjunctum above it is characterised by progressive corneodesmosomal dissolution, the compactum is characterised by intact corneodesmosomes, fully organised lamellar lipid bilayers, and the highest corneocyte density in the stratum corneum.

It is the compactum that most directly corresponds to the “bricks and mortar” model described in the section above. The lamellar lipid bilayers – ceramides, cholesterol, and free fatty acids in repeating organised phases – reach their most complete and tightly ordered arrangement in the compactum, having been fully processed from lamellar body precursors by the acidic sphingomyelinase and beta-glucocerebrosidase enzymes whose activity is maintained by the acid pH generated in this zone. The corneodesmosomes here are unprocessed by the KLK cascade: LEKTI inhibition of KLK5 at the lower stratum corneum’s relatively less acidic pH holds protease activity in check, ensuring that corneodesmosomal integrity is maintained at exactly the layer where barrier structural function requires it. ^[4]

Understanding the compactum as the zone of intact barrier function changes how barrier disruption and recovery should be interpreted clinically. Mild exfoliation, well-calibrated chemical peels, and even low-energy fractional laser treatments disrupt the disjunctum – removing accumulated surface cells and temporarily thinning the overall stratum corneum – whilst the compactum remains structurally competent, lipid matrix intact, and capable of rapid barrier recovery. Recovery is fast because the structural foundation is untouched. By contrast, over-exfoliation that penetrates into the compactum – through excessive concentration, very low pH, or frequency beyond the barrier’s regeneration capacity – disrupts the lipid lamellar organisation, permits the KLK cascade to spread beyond the disjunctum, and produces the barrier failure characterised by elevated TEWL, increased irritant sensitivity, and the prolonged recovery that clients describe as their skin “breaking down.” ^[3]

Disjunctum vs. Compactum: Functional Summary

The Acid Mantle and pH Dependency

Healthy stratum corneum surface pH sits between approximately 4.5 and 5.5. This is not incidental, it is the pH range at which the two enzymes responsible for the final processing of ceramide precursors into active ceramides, acidic sphingomyelinase and beta-glucocerebrosidase, operate at optimal activity. At neutral or alkaline pH, both enzymes become significantly less active, and ceramide production from the lamellar body precursor pool slows measurably even when upstream synthesis is intact. The acid mantle is therefore not a standalone antimicrobial feature, it is an active prerequisite for the barrier’s own lipid maintenance machinery.

Sources of pH disruption that impair this system include alkaline surfactants in cleansers, hard water mineral exposure, and filaggrin deficiency – which reduces the urocanic acid and pyrrolidone carboxylic acid that filaggrin degradation contributes to the acid mantle. The Filaggrin page describes this relationship in detail, and the cross-dependency between filaggrin status and stratum corneum lipid processing is one of the clearest examples in barrier biology of how two apparently separate components are mechanistically coupled.

The pH “Switch” (Enzyme Activity)

How the Stratum Corneum Changes with Age

The stratum corneum undergoes measurable changes through both chronological ageing and hormonal transition that impair its barrier performance without necessarily being visible at the surface.

Corneocyte transit time through the stratum corneum increases with age – from approximately 20 days in younger adults to 30 days or more in older adults – meaning that the surface is occupied by older, more structurally compromised cells for longer before desquamation removes them. Lipid composition shifts with age: ceramide content declines, and the chain length distribution of free fatty acids changes in ways that reduce lamellar phase organisation. Post-menopause, oestrogen withdrawal reduces the activity of enzymes involved in ceramide synthesis, contributing an additional hormone-mediated route to the lipid matrix deterioration described in the Ceramides page.

The result is a stratum corneum that retains its basic architecture but performs it less efficiently: higher TEWL, greater vulnerability to irritant penetration, slower recovery following disruption, and a compromised acid mantle that further impairs the lipid processing the barrier needs to self-maintain.

Aging and the Stratum Corneum